货号 |
品名 |
化学名 |
CAS号 |
分子量 |
分子式 |
Synonyms |
纯度 |
包装 |
价格 |
品牌 |
CX90418-1G |
L-allysine ethylene acetal |
(S)-2-amino-5-(1,3-dioxolan-2-yl)-pentanoic acid |
215054-80-1 |
189.21 |
C8 H15 N O4 |
H-Aea-OH |
99% |
1 G |
6200 |
chiralix |
CX90418-2G |
L-allysine ethylene acetal |
(S)-2-amino-5-(1,3-dioxolan-2-yl)-pentanoic acid |
215054-80-1 |
189.21 |
C8 H15 N O4 |
H-Aea-OH |
99% |
2 G |
10600 |
chiralix |
CX90418-5G |
L-allysine ethylene acetal |
(S)-2-amino-5-(1,3-dioxolan-2-yl)-pentanoic acid |
215054-80-1 |
189.21 |
C8 H15 N O4 |
H-Aea-OH |
99% |
5 G |
19900 |
chiralix |
CX60325-200MG |
D-homopropargylglycine |
(R)-2-aminohex-5-ynoic acid |
211054-02-3 |
127.14 |
C6 H9 N O2 |
H-D-Hpg-OH |
>98% |
200 MG |
4800 |
chiralix |
CX60325-500MG |
D-homopropargylglycine |
(R)-2-aminohex-5-ynoic acid |
211054-02-3 |
127.14 |
C6 H9 N O2 |
H-D-Hpg-OH |
>98% |
500 MG |
9800 |
chiralix |
CX60325-1G |
D-homopropargylglycine |
(R)-2-aminohex-5-ynoic acid |
211054-02-3 |
127.14 |
C6 H9 N O2 |
H-D-Hpg-OH |
>98% |
1 G |
16000 |
chiralix |
CX80065-500MG |
Fmoc-L-homopropargylglycine |
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoic acid |
942518-21-0 |
349.38 |
C21 H19 N O4 |
Fmoc-Hpg-OH |
>97% |
500 MG |
11200 |
chiralix |
CX80065-1G |
Fmoc-L-homopropargylglycine |
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoic acid |
942518-21-0 |
349.38 |
C21 H19 N O4 |
Fmoc-Hpg-OH |
>97% |
1 G |
18400 |
chiralix |
CX90138-200MG |
L-homopropargylglycine |
(S)-2-aminohex-5-ynoic acid |
98891-36-2 |
127.14 |
C6 H9 N O2 |
H-Hpg-OH |
>98% |
200 MG |
4800 |
chiralix |
CX90138-500MG |
L-homopropargylglycine |
(S)-2-aminohex-5-ynoic acid |
98891-36-2 |
127.14 |
C6 H9 N O2 |
H-Hpg-OH |
>98% |
500 MG |
9800 |
chiralix |
CX90138-1G |
L-homopropargylglycine |
(S)-2-aminohex-5-ynoic acid |
98891-36-2 |
127.14 |
C6 H9 N O2 |
H-Hpg-OH |
>98% |
1 G |
16000 |
chiralix |
CX56292-500MG |
(3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylic acid |
(3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylic acid |
108646-25-9 |
156.14 |
C7 H8 O4 |
|
>97% |
500 MG |
6000 |
chiralix |
CX56292-1G |
(3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylic acid |
(3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylic acid |
108646-25-9 |
156.14 |
C7 H8 O4 |
|
>97% |
1 G |
9800 |
chiralix |
CX24022-500MG |
(5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid |
(5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid |
38127-17-2 |
155.15 |
C7 H9 N O3 |
|
>98% |
500 MG |
6000 |
chiralix |
CX24022-1G |
(5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid |
(5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid |
38127-17-2 |
155.15 |
C7 H9 N O3 |
|
>98% |
1 G |
9800 |
chiralix |
CX41399-1G |
(S)-beta3-phenylalanine |
(S)-3-amino-3-phenylpropanoic acid |
40856-44-8 |
165.19 |
C9 H11 N O2 |
|
99% |
1 G |
2200 |
chiralix |
CX41399-2G |
(S)-beta3-phenylalanine |
(S)-3-amino-3-phenylpropanoic acid |
40856-44-8 |
165.19 |
C9 H11 N O2 |
|
99% |
2 G |
3800 |
chiralix |
CX41399-5G |
(S)-beta3-phenylalanine |
(S)-3-amino-3-phenylpropanoic acid |
40856-44-8 |
165.19 |
C9 H11 N O2 |
|
99% |
5 G |
7200 |
chiralix |
CX64691-1G |
D-tert-leucine |
(R)-2-amino-3,3-dimethylbutyric acid |
26782-71-8 |
131.17 |
C6 H13 N O2 |
H-D-tert-Leu-OH |
99% |
1 G |
2200 |
chiralix |
CX64691-2G |
D-tert-leucine |
(R)-2-amino-3,3-dimethylbutyric acid |
26782-71-8 |
131.17 |
C6 H13 N O2 |
H-D-tert-Leu-OH |
99% |
2 G |
3800 |
chiralix |
CX64691-5G |
D-tert-leucine |
(R)-2-amino-3,3-dimethylbutyric acid |
26782-71-8 |
131.17 |
C6 H13 N O2 |
H-D-tert-Leu-OH |
99% |
5 G |
7200 |
chiralix |
CX97471-500MG |
(S)-alpha-methyl-phenylglycine |
(S)-2-amino-2-phenylpropanoic acid |
13398-26-0 |
165.19 |
C9 H11 N O2 |
(S)-H-Mpg-OH |
>98% |
500 MG |
5200 |
chiralix |
CX97471-1G |
(S)-alpha-methyl-phenylglycine |
(S)-2-amino-2-phenylpropanoic acid |
13398-26-0 |
165.19 |
C9 H11 N O2 |
(S)-H-Mpg-OH |
>98% |
1 G |
9000 |
chiralix |
CX97471-2G |
(S)-alpha-methyl-phenylglycine |
(S)-2-amino-2-phenylpropanoic acid |
13398-26-0 |
165.19 |
C9 H11 N O2 |
(S)-H-Mpg-OH |
>98% |
2 G |
14800 |
chiralix |
CX58692-1G |
(S)-allylglycinol hydrochloride |
(S)-2-aminopent-4-en-1-ol hydrochloride |
926660-03-9 |
137.61 |
C5 H12 Cl N O |
|
>98% |
1 G |
7400 |
chiralix |
CX58692-2G |
(S)-allylglycinol hydrochloride |
(S)-2-aminopent-4-en-1-ol hydrochloride |
926660-03-9 |
137.61 |
C5 H12 Cl N O |
|
>98% |
2 G |
12800 |
chiralix |
CX40529-1G |
(S)-propargylglycinol hydrochloride |
(S)-2-aminopent-4-yn-1-ol hydrochloride |
Not available |
135.59 |
C5 H10 Cl N O |
|
>98% |
1 G |
8200 |
chiralix |
CX40529-2G |
(S)-propargylglycinol hydrochloride |
(S)-2-aminopent-4-yn-1-ol hydrochloride |
Not available |
135.59 |
C5 H10 Cl N O |
|
>98% |
2 G |
14000 |
chiralix |
CX80916-500MG |
bis(N-Cbz)-2-deoxystreptamine |
benzyl 4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate |
6216-32-6 |
430.45 |
C22 H26 N2 O7 |
bis-Z-2-DOS |
>95% |
500 MG |
6200 |
chiralix |
CX80916-1G |
bis(N-Cbz)-2-deoxystreptamine |
benzyl 4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate |
6216-32-6 |
430.45 |
C22 H26 N2 O7 |
bis-Z-2-DOS |
>95% |
1 G |
10800 |
chiralix |
CX93851-100MG |
(2S,5R)-5-hydroxypipecolic acid hydrochloride |
(2S,5R)-5-hydroxypiperidine-2-carboxylic acid hydrochloride |
824943-40-0 |
181.62 |
C6 H12 Cl N O3 |
|
>98% |
100 MG |
3800 |
chiralix |
CX93851-500MG |
(2S,5R)-5-hydroxypipecolic acid hydrochloride |
(2S,5R)-5-hydroxypiperidine-2-carboxylic acid hydrochloride |
824943-40-0 |
181.62 |
C6 H12 Cl N O3 |
|
>98% |
500 MG |
12600 |
chiralix |
CX93851-1G |
(2S,5R)-5-hydroxypipecolic acid hydrochloride |
(2S,5R)-5-hydroxypiperidine-2-carboxylic acid hydrochloride |
824943-40-0 |
181.62 |
C6 H12 Cl N O3 |
|
>98% |
1 G |
19600 |
chiralix |
CX19922-1G |
(S)-beta3-phenylalanine methyl ester hydrochloride |
(S)-methyl 3-amino-3-phenylpropanoate hydrochloride |
144494-72-4 |
215.68 |
C10 H14 Cl N O2 |
|
>98% |
1 G |
3000 |
chiralix |
CX19922-2G |
(S)-beta3-phenylalanine methyl ester hydrochloride |
(S)-methyl 3-amino-3-phenylpropanoate hydrochloride |
144494-72-4 |
215.68 |
C10 H14 Cl N O2 |
|
>98% |
2 G |
5200 |
chiralix |
CX19922-5G |
(S)-beta3-phenylalanine methyl ester hydrochloride |
(S)-methyl 3-amino-3-phenylpropanoate hydrochloride |
144494-72-4 |
215.68 |
C10 H14 Cl N O2 |
|
>98% |
5 G |
9800 |
chiralix |
CX62577-10MG |
6,8a-diepi-castanospermine |
(1S,6R,7R,8R,8aS)-octahydroindolizine-1,6,7,8-tetraol |
106798-21-0 |
189.21 |
C8 H15 N O4 |
|
>98% |
10 MG |
3600 |
chiralix |
CX62577-50MG |
6,8a-diepi-castanospermine |
(1S,6R,7R,8R,8aS)-octahydroindolizine-1,6,7,8-tetraol |
106798-21-0 |
189.21 |
C8 H15 N O4 |
|
>98% |
50 MG |
11800 |
chiralix |
CX25404-1G |
Fmoc-L-azidoornithine |
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-azidopentanoic acid |
1097192-04-5 |
380.40 |
C20 H20 N4 O4 |
Fmoc-Orn(N2)-OH |
>98% |
1 G |
3400 |
chiralix |
CX25404-5G |
Fmoc-L-azidoornithine |
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-azidopentanoic acid |
1097192-04-5 |
380.40 |
C20 H20 N4 O4 |
Fmoc-Orn(N2)-OH |
>98% |
5 G |
12000 |
chiralix |
CX23880-5MG |
rac-GR24 |
(3aR*,8bS*,E)-3-(((R*)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-inde,2-b]furan-2-one |
76974-79-3 |
298.29 |
C17 H14 O5 |
|
>98% |
5 MG |
5000 |
chiralix |
CX23880-20MG |
rac-GR24 |
(3aR*,8bS*,E)-3-(((R*)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-inde,2-b]furan-2-one |
76974-79-3 |
298.29 |
C17 H14 O5 |
|
>98% |
20 MG |
15000 |
chiralix |
CX23880-100MG |
rac-GR24 |
(3aR*,8bS*,E)-3-(((R*)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-inde,2-b]furan-2-one |
76974-79-3 |
298.29 |
C17 H14 O5 |
|
>98% |
100 MG |
35000 |
chiralix |
CX38605-1G |
Fmoc-L-allysine ethylene acetal |
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid |
Not available |
411.45 |
C23 H25 N O6 |
Fmoc-Aea-OH |
>97% |
1 G |
7200 |
chiralix |
CX38605-2G |
Fmoc-L-allysine ethylene acetal |
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid |
Not available |
411.45 |
C23 H25 N O6 |
Fmoc-Aea-OH |
>97% |
2 G |
12400 |
chiralix |
CX59650-1G |
Fmoc-L-azidohomoalanine |
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-4-azidobutanoic acid |
942518-20-9 |
366.37 |
C19 H18 N4 O4 |
Fmoc-Azh-OH |
>98% |
1 G |
3400 |
chiralix |
CX59650-5G |
Fmoc-L-azidohomoalanine |
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-4-azidobutanoic acid |
942518-20-9 |
366.37 |
C19 H18 N4 O4 |
Fmoc-Azh-OH |
>98% |
5 G |
12000 |
chiralix |
CX94894-200MG |
L-bishomopropargylglycine |
(S)-2-aminohept-6-ynoic acid |
835627-45-7 |
141.17 |
C7 H11 N O2 |
H-Bpg-OH |
>98% |
200 MG |
4400 |
chiralix |
CX94894-500MG |
L-bishomopropargylglycine |
(S)-2-aminohept-6-ynoic acid |
835627-45-7 |
141.17 |
C7 H11 N O2 |
H-Bpg-OH |
>98% |
500 MG |
9000 |
chiralix |
CX94894-1G |
L-bishomopropargylglycine |
(S)-2-aminohept-6-ynoic acid |
835627-45-7 |
141.17 |
C7 H11 N O2 |
H-Bpg-OH |
>98% |
1 G |
14600 |
chiralix |
CX13745-1G |
(R)-propargylglycinol hydrochloride |
(R)-2-aminopent-4-yn-1-ol hydrochloride |
Not available |
135.59 |
C5 H10 Cl N O |
|
>98% |
1 G |
8200 |
chiralix |
CX13745-2G |
(R)-propargylglycinol hydrochloride |
(R)-2-aminopent-4-yn-1-ol hydrochloride |
Not available |
135.59 |
C5 H10 Cl N O |
|
>98% |
2 G |
14000 |
chiralix |
CX78500-1G |
(R)-allylglycinol hydrochloride |
(R)-2-aminopent-4-en-1-ol hydrochloride |
926660-30-2 |
137.61 |
C5 H12 Cl N O |
|
>98% |
1 G |
7400 |
chiralix |
CX78500-2G |
(R)-allylglycinol hydrochloride |
(R)-2-aminopent-4-en-1-ol hydrochloride |
926660-30-2 |
137.61 |
C5 H12 Cl N O |
|
>98% |
2 G |
12800 |
chiralix |
CX69324-500MG |
bis(N-Boc)-2-deoxystreptamine |
tert-butyl (1R,3S,4R,5r,6S)-4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate |
189157-45-7 |
362.42 |
C16 H30 N2 O7 |
bis-Boc-2-DOS |
>95% |
500 MG |
6200 |
chiralix |
CX69324-1G |
bis(N-Boc)-2-deoxystreptamine |
tert-butyl (1R,3S,4R,5r,6S)-4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate |
189157-45-7 |
362.42 |
C16 H30 N2 O7 |
bis-Boc-2-DOS |
>95% |
1 G |
10800 |
chiralix |
CX96388-1G |
Boc-L-allysine ethylene acetal |
(S)-2-(tert-butoxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid |
Not available |
289.32 |
C13 H23 N O6 |
Boc-Aea-OH |
>98% |
1 G |
6200 |
chiralix |
CX96388-2G |
Boc-L-allysine ethylene acetal |
(S)-2-(tert-butoxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid |
Not available |
289.32 |
C13 H23 N O6 |
Boc-Aea-OH |
>98% |
2 G |
10600 |
chiralix |
CX96388-5G |
Boc-L-allysine ethylene acetal |
(S)-2-(tert-butoxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid |
Not available |
289.32 |
C13 H23 N O6 |
Boc-Aea-OH |
>98% |
5 G |
19900 |
chiralix |
CX42388-1G |
Cbz-L-allysine ethylene acetal |
(S)-2-(benzyloxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid |
852822-01-6 |
323.34 |
C16 H21 N O6 |
Z-Aea-OH |
>98% |
1 G |
6200 |
chiralix |
CX42388-2G |
Cbz-L-allysine ethylene acetal |
(S)-2-(benzyloxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid |
852822-01-6 |
323.34 |
C16 H21 N O6 |
Z-Aea-OH |
>98% |
2 G |
10600 |
chiralix |
CX42388-5G |
Cbz-L-allysine ethylene acetal |
(S)-2-(benzyloxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid |
852822-01-6 |
323.34 |
C16 H21 N O6 |
Z-Aea-OH |
>98% |
5 G |
19900 |
chiralix |
CX44656-500MG |
Boc-L-homopropargylglycine |
(S)-2-(tert-butoxycarbonylamino)hex-5-ynoic acid |
208522-16-1 |
227.26 |
C11 H17 N O4 |
Boc-Hpg-OH |
>98% |
500 MG |
9800 |
chiralix |
CX44656-1G |
Boc-L-homopropargylglycine |
(S)-2-(tert-butoxycarbonylamino)hex-5-ynoic acid |
208522-16-1 |
227.26 |
C11 H17 N O4 |
Boc-Hpg-OH |
>98% |
1 G |
16000 |
chiralix |
CX69013-500MG |
Cbz-L-homopropargylglycine |
(S)-2-(benzyloxycarbonylamino)hex-5-ynoic acid |
Not available |
261.27 |
C14 H15 N O4 |
Z-Hpg-OH |
>98% |
500 MG |
9800 |
chiralix |
CX69013-1G |
Cbz-L-homopropargylglycine |
(S)-2-(benzyloxycarbonylamino)hex-5-ynoic acid |
Not available |
261.27 |
C14 H15 N O4 |
Z-Hpg-OH |
>98% |
1 G |
16000 |
chiralix |
CX54783-500MG |
Boc-D-homopropargylglycine |
(R)-2-(tert-butoxycarbonylamino)hex-5-ynoic acid |
Not available |
227.26 |
C11 H17 N O4 |
Boc-D-Hpg-OH |
>98% |
500 MG |
9800 |
chiralix |
CX54783-1G |
Boc-D-homopropargylglycine |
(R)-2-(tert-butoxycarbonylamino)hex-5-ynoic acid |
Not available |
227.26 |
C11 H17 N O4 |
Boc-D-Hpg-OH |
>98% |
1 G |
16000 |
chiralix |
CX14845-500MG |
Cbz-D-homopropargylglycine |
(R)-2-(benzyloxycarbonylamino)hex-5-ynoic acid |
Not available |
261.27 |
C14 H15 N O4 |
Z-D-Hpg-OH |
>98% |
500 MG |
9800 |
chiralix |
CX14845-1G |
Cbz-D-homopropargylglycine |
(R)-2-(benzyloxycarbonylamino)hex-5-ynoic acid |
Not available |
261.27 |
C14 H15 N O4 |
Z-D-Hpg-OH |
>98% |
1 G |
16000 |
chiralix |
CX87818-500MG |
Fmoc-D-homopropargylglycine |
(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoic acid |
Not available |
349.38 |
C21 H19 N O4 |
Fmoc-D-Hpg-OH |
>97% |
500 MG |
11200 |
chiralix |
CX87818-1G |
Fmoc-D-homopropargylglycine |
(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoic acid |
Not available |
349.38 |
C21 H19 N O4 |
Fmoc-D-Hpg-OH |
>97% |
1 G |
18400 |
chiralix |
CX57816-500MG |
Fmoc-L-bishomopropargylglycine |
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoic acid |
Not available |
363.41 |
C22 H21 N O4 |
Fmoc-Bpg-OH |
>97% |
500 MG |
10400 |
chiralix |
CX57816-1G |
Fmoc-L-bishomopropargylglycine |
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoic acid |
Not available |
363.41 |
C22 H21 N O4 |
Fmoc-Bpg-OH |
>97% |
1 G |
16800 |
chiralix |
CX32424-200MG |
D-bishomopropargylglycine |
(R)-2-aminohept-6-ynoic acid |
211054-03-4 |
141.17 |
C7 H11 N O2 |
H-D-Bpg-OH |
>98% |
200 MG |
4400 |
chiralix |
CX32424-500MG |
D-bishomopropargylglycine |
(R)-2-aminohept-6-ynoic acid |
211054-03-4 |
141.17 |
C7 H11 N O2 |
H-D-Bpg-OH |
>98% |
500 MG |
9000 |
chiralix |
CX32424-1G |
D-bishomopropargylglycine |
(R)-2-aminohept-6-ynoic acid |
211054-03-4 |
141.17 |
C7 H11 N O2 |
H-D-Bpg-OH |
>98% |
1 G |
14600 |
chiralix |
CX80846-500MG |
Fmoc-D-bishomopropargylglycine |
(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoic acid |
Not available |
363.41 |
C22 H21 N O4 |
Fmoc-D-Bpg-OH |
>97% |
500 MG |
10400 |
chiralix |
CX80846-1G |
Fmoc-D-bishomopropargylglycine |
(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoic acid |
Not available |
363.41 |
C22 H21 N O4 |
Fmoc-D-Bpg-OH |
>97% |
1 G |
16800 |
chiralix |
CX52977-1G |
(S)-Boc-beta3-phenylalanine |
(S)-3-(tert-butoxycarbonylamino)-3-phenylpropanoic acid |
103365-47-5 |
265.30 |
C14 H19 N O4 |
|
>98% |
1 G |
2200 |
chiralix |
CX52977-2G |
(S)-Boc-beta3-phenylalanine |
(S)-3-(tert-butoxycarbonylamino)-3-phenylpropanoic acid |
103365-47-5 |
265.30 |
C14 H19 N O4 |
|
>98% |
2 G |
3800 |
chiralix |
CX52977-5G |
(S)-Boc-beta3-phenylalanine |
(S)-3-(tert-butoxycarbonylamino)-3-phenylpropanoic acid |
103365-47-5 |
265.30 |
C14 H19 N O4 |
|
>98% |
5 G |
7200 |
chiralix |
CX79659-1G |
(S)-Cbz-beta3-phenylalanine |
(S)-3-(benzyloxycarbonylamino)-3-phenylpropanoic acid |
14441-08-8 |
299.32 |
C17 H17 N O4 |
|
>98% |
1 G |
2200 |
chiralix |
CX79659-2G |
(S)-Cbz-beta3-phenylalanine |
(S)-3-(benzyloxycarbonylamino)-3-phenylpropanoic acid |
14441-08-8 |
299.32 |
C17 H17 N O4 |
|
>98% |
2 G |
3800 |
chiralix |
CX79659-5G |
(S)-Cbz-beta3-phenylalanine |
(S)-3-(benzyloxycarbonylamino)-3-phenylpropanoic acid |
14441-08-8 |
299.32 |
C17 H17 N O4 |
|
>98% |
5 G |
7200 |
chiralix |
CX56872-1G |
(S)-Fmoc-beta3-phenylalanine |
(S)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-phenylpropanoic acid |
209252-15-3 |
387.43 |
C24 H21 N O4 |
|
>98% |
1 G |
2600 |
chiralix |
CX56872-2G |
(S)-Fmoc-beta3-phenylalanine |
(S)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-phenylpropanoic acid |
209252-15-3 |
387.43 |
C24 H21 N O4 |
|
>98% |
2 G |
4400 |
chiralix |
CX56872-5G |
(S)-Fmoc-beta3-phenylalanine |
(S)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-phenylpropanoic acid |
209252-15-3 |
387.43 |
C24 H21 N O4 |
|
>98% |
5 G |
8600 |
chiralix |
CX44048-1G |
Boc-D-tert-leucine |
(R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoic acid |
124655-17-0 |
231.29 |
C11 H21 N O4 |
Boc-D-tert-Leu-OH |
>98% |
1 G |
2200 |
chiralix |
CX44048-2G |
Boc-D-tert-leucine |
(R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoic acid |
124655-17-0 |
231.29 |
C11 H21 N O4 |
Boc-D-tert-Leu-OH |
>98% |
2 G |
3800 |
chiralix |
CX44048-5G |
Boc-D-tert-leucine |
(R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoic acid |
124655-17-0 |
231.29 |
C11 H21 N O4 |
Boc-D-tert-Leu-OH |
>98% |
5 G |
7200 |
chiralix |
CX22855-1G |
Fmoc-D-tert-leucine |
(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3,3-dimethylbutanoic acid |
198543-64-5 |
353.41 |
C21 H23 N O4 |
Fmoc-D-tert-Leu-OH |
>97% |
1 G |
2600 |
chiralix |
CX22855-2G |
Fmoc-D-tert-leucine |
(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3,3-dimethylbutanoic acid |
198543-64-5 |
353.41 |
C21 H23 N O4 |
Fmoc-D-tert-Leu-OH |
>97% |
2 G |
4400 |
chiralix |
CX22855-5G |
Fmoc-D-tert-leucine |
(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3,3-dimethylbutanoic acid |
198543-64-5 |
353.41 |
C21 H23 N O4 |
Fmoc-D-tert-Leu-OH |
>97% |
5 G |
8600 |
chiralix |
CX28901-1G |
(S)-Boc-alpha-methyl-phenylglycine |
(S)-2-(tert-butoxycarbonylamino)-2-phenylpropanoic acid |
802541-88-4 |
265.30 |
C14 H19 N O4 |
(S)-Boc-Mpg-OH |
>98% |
1 G |
9000 |
chiralix |
CX28901-2G |
(S)-Boc-alpha-methyl-phenylglycine |
(S)-2-(tert-butoxycarbonylamino)-2-phenylpropanoic acid |
802541-88-4 |
265.30 |
C14 H19 N O4 |
(S)-Boc-Mpg-OH |
>98% |
2 G |
14800 |
chiralix |
CX28344-1G |
(S)-Fmoc-alpha-methyl-phenylglycine |
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoic acid |
881921-11-5 |
387.43 |
C24 H21 N O4 |
(S)-Fmoc-Mpg-OH |
>98% |
1 G |
10400 |
chiralix |
CX28344-2G |
(S)-Fmoc-alpha-methyl-phenylglycine |
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoic acid |
881921-11-5 |
387.43 |
C24 H21 N O4 |
(S)-Fmoc-Mpg-OH |
>98% |
2 G |
17200 |
chiralix |
CX93005-1G |
Fmoc-L-azidoalanine |
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-azidopropanoic acid |
684270-46-0 |
352.34 |
C18 H16 N4 O4 |
Fmoc-Aza-OH |
>98% |
1 G |
3400 |
chiralix |
CX93005-5G |
Fmoc-L-azidoalanine |
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-azidopropanoic acid |
684270-46-0 |
352.34 |
C18 H16 N4 O4 |
Fmoc-Aza-OH |
>98% |
5 G |
12000 |
chiralix |
CX90286-200MG |
bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine |
4t,6t-diazidocyclohexane-1r,2t,3c-triyl triacetate |
90852-19-0 |
340.29 |
C12 H16 N6 O6 |
2-DOS diazide triacetate |
>98% |
200 MG |
4200 |
chiralix |
CX90286-500MG |
bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine |
4t,6t-diazidocyclohexane-1r,2t,3c-triyl triacetate |
90852-19-0 |
340.29 |
C12 H16 N6 O6 |
2-DOS diazide triacetate |
>98% |
500 MG |
8800 |
chiralix |
CX90286-1G |
bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine |
4t,6t-diazidocyclohexane-1r,2t,3c-triyl triacetate |
90852-19-0 |
340.29 |
C12 H16 N6 O6 |
2-DOS diazide triacetate |
>98% |
1 G |
15200 |
chiralix |
CX44848-200MG |
(R)-4-oxopipecolic acid ethylene acetal |
(R)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid |
Not available |
187.19 |
C8 H13 N O4 |
|
>98% |
200 MG |
5200 |
chiralix |
CX44848-500MG |
(R)-4-oxopipecolic acid ethylene acetal |
(R)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid |
Not available |
187.19 |
C8 H13 N O4 |
|
>98% |
500 MG |
11000 |
chiralix |
CX44848-1G |
(R)-4-oxopipecolic acid ethylene acetal |
(R)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid |
Not available |
187.19 |
C8 H13 N O4 |
|
>98% |
1 G |
19200 |
chiralix |
CX45124-500MG |
(R)-alpha-methyl-phenylglycine |
(R)-2-amino-2-phenylpropanoic acid |
29738-09-8 |
165.19 |
C9 H11 N O2 |
(R)-H-Mpg-OH |
>98% |
500 MG |
6200 |
chiralix |
CX45124-1G |
(R)-alpha-methyl-phenylglycine |
(R)-2-amino-2-phenylpropanoic acid |
29738-09-8 |
165.19 |
C9 H11 N O2 |
(R)-H-Mpg-OH |
>98% |
1 G |
10400 |
chiralix |
CX45124-2G |
(R)-alpha-methyl-phenylglycine |
(R)-2-amino-2-phenylpropanoic acid |
29738-09-8 |
165.19 |
C9 H11 N O2 |
(R)-H-Mpg-OH |
>98% |
2 G |
17200 |
chiralix |
CX43844-1G |
L-azidoleucine CHA salt |
cyclohexanaminium (S)-2-azido-4-methylpentanoate |
Not available |
256.34 |
C12 H24 N4 O2 |
N3-Leu-OH · CHA |
>98% |
1 G |
2800 |
chiralix |
CX43844-5G |
L-azidoleucine CHA salt |
cyclohexanaminium (S)-2-azido-4-methylpentanoate |
Not available |
256.34 |
C12 H24 N4 O2 |
N3-Leu-OH · CHA |
>98% |
5 G |
10600 |
chiralix |
CX66793-1G |
L-azidovaline CHA salt |
cyclohexanaminium (S)-2-azido-3-methylbutanoate |
Not available |
242.32 |
C11 H22 N4 O2 |
N3-Val-OH · CHA |
>98% |
1 G |
2600 |
chiralix |
CX66793-5G |
L-azidovaline CHA salt |
cyclohexanaminium (S)-2-azido-3-methylbutanoate |
Not available |
242.32 |
C11 H22 N4 O2 |
N3-Val-OH · CHA |
>98% |
5 G |
9800 |
chiralix |
CX90285-1G |
L-azidotryptophan CHA salt |
cyclohexanaminium (S)-2-azido-3-(1H-indol-2-yl)propanoate |
Not available |
329.40 |
C17 H23 N5 O2 |
N3-Trp-OH · CHA |
>98% |
1 G |
2400 |
chiralix |
CX90285-5G |
L-azidotryptophan CHA salt |
cyclohexanaminium (S)-2-azido-3-(1H-indol-2-yl)propanoate |
Not available |
329.40 |
C17 H23 N5 O2 |
N3-Trp-OH · CHA |
>98% |
5 G |
9000 |
chiralix |
CX32182-1G |
L-azidoalanine CHA salt |
cyclohexanaminium (S)-2-azidopropanoate |
Not available |
214.26 |
C9 H18 N4 O2 |
N3-Ala-OH · CHA |
>98% |
1 G |
2800 |
chiralix |
CX32182-5G |
L-azidoalanine CHA salt |
cyclohexanaminium (S)-2-azidopropanoate |
Not available |
214.26 |
C9 H18 N4 O2 |
N3-Ala-OH · CHA |
>98% |
5 G |
10600 |
chiralix |
CX33085-1G |
L-azidophenylalanine CHA salt |
cyclohexanaminium (S)-2-azido-3-phenylpropanoate |
Not available |
290.36 |
C15 H22 N4 O2 |
N3-Phe-OH · CHA |
>98% |
1 G |
2400 |
chiralix |
CX33085-5G |
L-azidophenylalanine CHA salt |
cyclohexanaminium (S)-2-azido-3-phenylpropanoate |
Not available |
290.36 |
C15 H22 N4 O2 |
N3-Phe-OH · CHA |
>98% |
5 G |
9000 |
chiralix |
CX37236-1G |
L-azidoisoleucine CHA salt |
cyclohexanaminium (2S,3S)-2-azido-3-methylpentanoate |
Not available |
256.34 |
C12 H24 N4 O2 |
N3-Ile-OH · CHA |
>98% |
1 G |
2800 |
chiralix |
CX37236-5G |
L-azidoisoleucine CHA salt |
cyclohexanaminium (2S,3S)-2-azido-3-methylpentanoate |
Not available |
256.34 |
C12 H24 N4 O2 |
N3-Ile-OH · CHA |
>98% |
5 G |
10600 |
chiralix |
CX81236-1G |
L-azidotyrosine CHA salt |
cyclohexanaminium (S)-2-azido-3-(4-hydroxyphenyl)propanoate |
Not available |
306.36 |
C15 H22 N4 O3 |
N3-Tyr-OH · CHA |
>97% |
1 G |
2800 |
chiralix |
CX81236-5G |
L-azidotyrosine CHA salt |
cyclohexanaminium (S)-2-azido-3-(4-hydroxyphenyl)propanoate |
Not available |
306.36 |
C15 H22 N4 O3 |
N3-Tyr-OH · CHA |
>97% |
5 G |
10600 |
chiralix |
CX84940-1G |
L-azidomethionine CHA salt |
cyclohexanaminium (S)-2-azido-4-(methylthio)butanoate |
Not available |
274.38 |
C11 H22 N4 O2 S |
N3-Met-OH · CHA |
>98% |
1 G |
2600 |
chiralix |
CX84940-5G |
L-azidomethionine CHA salt |
cyclohexanaminium (S)-2-azido-4-(methylthio)butanoate |
Not available |
274.38 |
C11 H22 N4 O2 S |
N3-Met-OH · CHA |
>98% |
5 G |
9800 |
chiralix |
CX81456-200MG |
(S)-5-oxopipecolic acid ethylene acetal |
(S)-1,4-dioxa-7-azaspiro[4.5]decane-8-carboxylic acid |
Not available |
187.19 |
C8 H13 N O4 |
|
>98% |
200 MG |
5200 |
chiralix |
CX81456-500MG |
(S)-5-oxopipecolic acid ethylene acetal |
(S)-1,4-dioxa-7-azaspiro[4.5]decane-8-carboxylic acid |
Not available |
187.19 |
C8 H13 N O4 |
|
>98% |
500 MG |
11000 |
chiralix |
CX81456-1G |
(S)-5-oxopipecolic acid ethylene acetal |
(S)-1,4-dioxa-7-azaspiro[4.5]decane-8-carboxylic acid |
Not available |
187.19 |
C8 H13 N O4 |
|
>98% |
1 G |
19200 |
chiralix |
CX80632-1G |
L-azidothreonine tert-butyl ether CHA salt |
cyclohexanaminium (2S,3R)-2-azido-3-tert-butoxybutanoate |
Not available |
300.40 |
C14 H28 N4 O3 |
N3-Thr(OtBu)-OH · CHA |
>98% |
1 G |
2800 |
chiralix |
CX80632-5G |
L-azidothreonine tert-butyl ether CHA salt |
cyclohexanaminium (2S,3R)-2-azido-3-tert-butoxybutanoate |
Not available |
300.40 |
C14 H28 N4 O3 |
N3-Thr(OtBu)-OH · CHA |
>98% |
5 G |
10600 |
chiralix |
CX59871-1G |
L-azidoserine CHA salt |
cyclohexanaminium (S)-2-azido-3-hydroxypropanoate |
Not available |
230.26 |
C9 H18 N4 O3 |
N3-Ser-OH · CHA |
>98% |
1 G |
2600 |
chiralix |
CX59871-5G |
L-azidoserine CHA salt |
cyclohexanaminium (S)-2-azido-3-hydroxypropanoate |
Not available |
230.26 |
C9 H18 N4 O3 |
N3-Ser-OH · CHA |
>98% |
5 G |
9800 |
chiralix |
CX20625-1G |
L-azidoaspartic acid mono-tert-butyl ester CHA salt |
cyclohexanaminium (S)-2-azido-4-tert-butoxy-4-oxobutanoate |
Not available |
314.38 |
C14 H26 N4 O4 |
N3-Asp(OtBu)-OH · CHA |
>98% |
1 G |
2600 |
chiralix |
CX20625-5G |
L-azidoaspartic acid mono-tert-butyl ester CHA salt |
cyclohexanaminium (S)-2-azido-4-tert-butoxy-4-oxobutanoate |
Not available |
314.38 |
C14 H26 N4 O4 |
N3-Asp(OtBu)-OH · CHA |
>98% |
5 G |
9800 |
chiralix |
CX24163-1G |
L-azidoglutamic acid mono-tert-butyl ester CHA salt |
cyclohexanaminium (S)-2-azido-5-tert-butoxy-5-oxopentanoate |
Not available |
328.41 |
C15 H28 N4 O4 |
N3-Glu(OtBu)-OH · CHA |
>98% |
1 G |
2800 |
chiralix |
CX24163-5G |
L-azidoglutamic acid mono-tert-butyl ester CHA salt |
cyclohexanaminium (S)-2-azido-5-tert-butoxy-5-oxopentanoate |
Not available |
328.41 |
C15 H28 N4 O4 |
N3-Glu(OtBu)-OH · CHA |
>98% |
5 G |
10600 |
chiralix |
CX68680-1G |
L-azidotyrosine tert-butyl ether CHA salt |
cyclohexanaminium (S)-2-azido-3-(4-tert-butoxyphenyl)propanoate |
Not available |
362.47 |
C19 H30 N4 O3 |
N3-Tyr(OtBu)-OH · CHA |
>98% |
1 G |
2800 |
chiralix |
CX68680-5G |
L-azidotyrosine tert-butyl ether CHA salt |
cyclohexanaminium (S)-2-azido-3-(4-tert-butoxyphenyl)propanoate |
Not available |
362.47 |
C19 H30 N4 O3 |
N3-Tyr(OtBu)-OH · CHA |
>98% |
5 G |
10600 |
chiralix |
CX55921-1G |
L-azidoserine tert-butyl ether CHA salt |
cyclohexanaminium (S)-2-azido-3-tert-butoxypropanoate |
Not available |
286.37 |
C13 H26 N4 O3 |
N3-Ser(OtBu)-OH · CHA |
>98% |
1 G |
2800 |
chiralix |
CX55921-5G |
L-azidoserine tert-butyl ether CHA salt |
cyclohexanaminium (S)-2-azido-3-tert-butoxypropanoate |
Not available |
286.37 |
C13 H26 N4 O3 |
N3-Ser(OtBu)-OH · CHA |
>98% |
5 G |
10600 |
chiralix |
CX54776-200MG |
(S)-4-oxopipecolic acid ethylene acetal |
(S)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid |
356073-54-6 |
187.19 |
C8 H13 N O4 |
|
>98% |
200 MG |
5200 |
chiralix |
CX54776-500MG |
(S)-4-oxopipecolic acid ethylene acetal |
(S)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid |
356073-54-6 |
187.19 |
C8 H13 N O4 |
|
>98% |
500 MG |
11000 |
chiralix |
CX54776-1G |
(S)-4-oxopipecolic acid ethylene acetal |
(S)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid |
356073-54-6 |
187.19 |
C8 H13 N O4 |
|
>98% |
1 G |
19200 |
chiralix |
CX46058-1G |
D-azidovaline CHA salt |
cyclohexanaminium (R)-2-azido-3-methylbutanoate |
Not available |
242.32 |
C11 H22 N4 O2 |
N3-D-Val-OH · CHA |
>98% |
1 G |
3000 |
chiralix |
CX46058-5G |
D-azidovaline CHA salt |
cyclohexanaminium (R)-2-azido-3-methylbutanoate |
Not available |
242.32 |
C11 H22 N4 O2 |
N3-D-Val-OH · CHA |
>98% |
5 G |
11200 |
chiralix |
CX44158-1G |
D-azidoalanine CHA salt |
cyclohexanaminium (R)-2-azidopropanoate |
Not available |
214.26 |
C9 H18 N4 O2 |
N3-D-Ala-OH · CHA |
>98% |
1 G |
3400 |
chiralix |
CX44158-5G |
D-azidoalanine CHA salt |
cyclohexanaminium (R)-2-azidopropanoate |
Not available |
214.26 |
C9 H18 N4 O2 |
N3-D-Ala-OH · CHA |
>98% |
5 G |
12800 |
chiralix |
CX27954-1G |
D-azidophenylalanine CHA salt |
cyclohexanaminium (R)-2-azido-3-phenylpropanoate |
Not available |
290.36 |
C15 H22 N4 O2 |
D-N3-Phe-OH · CHA |
>98% |
1 G |
2800 |
chiralix |
CX27954-5G |
D-azidophenylalanine CHA salt |
cyclohexanaminium (R)-2-azido-3-phenylpropanoate |
Not available |
290.36 |
C15 H22 N4 O2 |
D-N3-Phe-OH · CHA |
>98% |
5 G |
10600 |
chiralix |
CX56656-1G |
D-azidomethionine CHA salt |
cyclohexanaminium (R)-2-azido-4-(methylthio)butanoate |
Not available |
274.38 |
C11 H22 N4 O2 S |
N3-D-Met-OH · CHA |
>98% |
1 G |
2800 |
chiralix |
CX56656-5G |
D-azidomethionine CHA salt |
cyclohexanaminium (R)-2-azido-4-(methylthio)butanoate |
Not available |
274.38 |
C11 H22 N4 O2 S |
N3-D-Met-OH · CHA |
>98% |
5 G |
10600 |
chiralix |
CX16129-500MG |
Cbz-L-bishomopropargylglycine CHA salt |
cyclohexanaminium (S)-2-(benzyloxycarbonylamino)hept-6-ynoate |
Not available |
374.47 |
C21 H30 N2 O4 |
Z-Bpg-OH · CHA |
>98% |
500 MG |
9000 |
chiralix |
CX16129-1G |
Cbz-L-bishomopropargylglycine CHA salt |
cyclohexanaminium (S)-2-(benzyloxycarbonylamino)hept-6-ynoate |
Not available |
374.47 |
C21 H30 N2 O4 |
Z-Bpg-OH · CHA |
>98% |
1 G |
14600 |
chiralix |
CX65817-1G |
(S)-Cbz-alpha-methyl-phenylglycine CHA salt |
cyclohexanaminium (S)-2-(benzyloxycarbonylamino)-2-phenylpropanoate |
Not available |
398.50 |
C23 H30 N2 O4 |
(S)-Cbz-Mpg-OH · CHA |
>98% |
1 G |
9000 |
chiralix |
CX65817-2G |
(S)-Cbz-alpha-methyl-phenylglycine CHA salt |
cyclohexanaminium (S)-2-(benzyloxycarbonylamino)-2-phenylpropanoate |
Not available |
398.50 |
C23 H30 N2 O4 |
(S)-Cbz-Mpg-OH · CHA |
>98% |
2 G |
14800 |
chiralix |
CX19691-500MG |
Boc-D-bishomopropargylglycine CHA salt |
cyclohexanaminium (R)-2-(tert-butoxycarbonylamino)hept-6-ynoate |
Not available |
340.46 |
C18 H32 N2 O4 |
Boc-D-Bpg-OH · CHA |
>98% |
500 MG |
9000 |
chiralix |
CX19691-1G |
Boc-D-bishomopropargylglycine CHA salt |
cyclohexanaminium (R)-2-(tert-butoxycarbonylamino)hept-6-ynoate |
Not available |
340.46 |
C18 H32 N2 O4 |
Boc-D-Bpg-OH · CHA |
>98% |
1 G |
14600 |
chiralix |
CX59796-500MG |
Boc-L-bishomopropargylglycine CHA salt |
cyclohexanaminium (S)-2-(tert-butoxycarbonylamino)hept-6-ynoate |
Not available |
340.46 |
C18 H32 N2 O4 |
Boc-Bpg-OH · CHA |
>98% |
500 MG |
9000 |
chiralix |
CX59796-1G |
Boc-L-bishomopropargylglycine CHA salt |
cyclohexanaminium (S)-2-(tert-butoxycarbonylamino)hept-6-ynoate |
Not available |
340.46 |
C18 H32 N2 O4 |
Boc-Bpg-OH · CHA |
>98% |
1 G |
14600 |
chiralix |
CX79723-1G |
(R)-Fmoc-alpha-methyl-phenylglycine |
(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoic acid |
881920-86-1 |
387.43 |
C24 H21 N O4 |
(R)-Fmoc-Mpg-OH |
>98% |
1 G |
12000 |
chiralix |
CX79723-2G |
(R)-Fmoc-alpha-methyl-phenylglycine |
(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoic acid |
881920-86-1 |
387.43 |
C24 H21 N O4 |
(R)-Fmoc-Mpg-OH |
>98% |
2 G |
19800 |
chiralix |
CX32015-1G |
Cbz-D-tert-leucine CHA salt |
cyclohexanaminium (R)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoate |
Not available |
364.48 |
C20 H32 N2 O4 |
Z-D-tert-Leu-OH · CHA |
>98% |
1 G |
2200 |
chiralix |
CX32015-2G |
Cbz-D-tert-leucine CHA salt |
cyclohexanaminium (R)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoate |
Not available |
364.48 |
C20 H32 N2 O4 |
Z-D-tert-Leu-OH · CHA |
>98% |
2 G |
3800 |
chiralix |
CX32015-5G |
Cbz-D-tert-leucine CHA salt |
cyclohexanaminium (R)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoate |
Not available |
364.48 |
C20 H32 N2 O4 |
Z-D-tert-Leu-OH · CHA |
>98% |
5 G |
7200 |
chiralix |
CX81118-1G |
Fmoc-L-azidolysine |
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-6-azidohexanoic acid |
159610-89-6 |
394.42 |
C21 H22 N4 O4 |
Fmoc-Lys(N2)-OH |
>98% |
1 G |
3400 |
chiralix |
CX81118-5G |
Fmoc-L-azidolysine |
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-6-azidohexanoic acid |
159610-89-6 |
394.42 |
C21 H22 N4 O4 |
Fmoc-Lys(N2)-OH |
>98% |
5 G |
12000 |
chiralix |
CX19587-500MG |
Cbz-D-bishomopropargylglycine CHA salt |
cyclohexanaminium (R)-2-(benzyloxycarbonylamino)hept-6-ynoate |
Not available |
374.47 |
C21 H30 N2 O4 |
Z-D-Bpg-OH · CHA |
>98% |
500 MG |
9000 |
chiralix |
CX19587-1G |
Cbz-D-bishomopropargylglycine CHA salt |
cyclohexanaminium (R)-2-(benzyloxycarbonylamino)hept-6-ynoate |
Not available |
374.47 |
C21 H30 N2 O4 |
Z-D-Bpg-OH · CHA |
>98% |
1 G |
14600 |
chiralix |
CX28021-500MG |
H-Arg(Boc)2-pNA |
(S,E)-tert-butyl (4-amino-5-(4-nitrophenylamino)-5-oxopentylamino)(tert-butoxycarbonylamino)methylenecarbamate |
Not available |
494.54 |
C22 H34 N6 O7 |
|
>97% |
500 MG |
6000 |
chiralix |
CX28021-1G |
H-Arg(Boc)2-pNA |
(S,E)-tert-butyl (4-amino-5-(4-nitrophenylamino)-5-oxopentylamino)(tert-butoxycarbonylamino)methylenecarbamate |
Not available |
494.54 |
C22 H34 N6 O7 |
|
>97% |
1 G |
11000 |
chiralix |
CX72798-1G |
D-azidoaspartic acid mono-tert-butyl ester CHA salt |
cyclohexanaminium (R)-2-azido-4-tert-butoxy-4-oxobutanoate |
Not available |
314.38 |
C14 H26 N4 O4 |
N3-D-Asp(OtBu)-OH · CHA |
>98% |
1 G |
6200 |
chiralix |
CX72798-5G |
D-azidoaspartic acid mono-tert-butyl ester CHA salt |
cyclohexanaminium (R)-2-azido-4-tert-butoxy-4-oxobutanoate |
Not available |
314.38 |
C14 H26 N4 O4 |
N3-D-Asp(OtBu)-OH · CHA |
>98% |
5 G |
23400 |
chiralix |
CX93516-1G |
D-azidoglutamic acid mono-tert-butyl ester CHA salt |
cyclohexanaminium (R)-2-azido-5-tert-butoxy-5-oxopentanoate |
Not available |
328.41 |
C15 H28 N4 O4 |
N3-D-Glu(OtBu)-OH · CHA |
>98% |
1 G |
5200 |
chiralix |
CX93516-5G |
D-azidoglutamic acid mono-tert-butyl ester CHA salt |
cyclohexanaminium (R)-2-azido-5-tert-butoxy-5-oxopentanoate |
Not available |
328.41 |
C15 H28 N4 O4 |
N3-D-Glu(OtBu)-OH · CHA |
>98% |
5 G |
19600 |
chiralix |
CX76762-1G |
D-azidoleucine CHA salt |
cyclohexanaminium (R)-2-azido-4-methylpentanoate |
Not available |
256.34 |
C12 H24 N4 O2 |
N3-D-Leu-OH · CHA |
>98% |
1 G |
3000 |
chiralix |
CX76762-5G |
D-azidoleucine CHA salt |
cyclohexanaminium (R)-2-azido-4-methylpentanoate |
Not available |
256.34 |
C12 H24 N4 O2 |
N3-D-Leu-OH · CHA |
>98% |
5 G |
11200 |
chiralix |
CX53333-1G |
D-azidoisoleucine CHA salt |
cyclohexanaminium (2R,3R)-2-azido-3-methylpentanoate |
Not available |
256.34 |
C12 H24 N4 O2 |
N3-D-Ile-OH · CHA |
>98% |
1 G |
9200 |
chiralix |
CX53333-2G |
D-azidoisoleucine CHA salt |
cyclohexanaminium (2R,3R)-2-azido-3-methylpentanoate |
Not available |
256.34 |
C12 H24 N4 O2 |
N3-D-Ile-OH · CHA |
>98% |
2 G |
16400 |
chiralix |
CX83245-1G |
D-azidotyrosine tert-butyl ether CHA salt |
cyclohexanaminium (R)-2-azido-3-(4-tert-butoxyphenyl)propanoate |
Not available |
362.47 |
C19 H30 N4 O3 |
N3-D-Tyr(OtBu)-OH · CHA |
>98% |
1 G |
5400 |
chiralix |
CX83245-5G |
D-azidotyrosine tert-butyl ether CHA salt |
cyclohexanaminium (R)-2-azido-3-(4-tert-butoxyphenyl)propanoate |
Not available |
362.47 |
C19 H30 N4 O3 |
N3-D-Tyr(OtBu)-OH · CHA |
>98% |
5 G |
20400 |
chiralix |
CX13425-1G |
D-azidoserine tert-butyl ether CHA salt |
cyclohexanaminium (R)-2-azido-3-tert-butoxypropanoate |
Not available |
286.37 |
C13 H26 N4 O3 |
N3-D-Ser(OtBu)-OH · CHA |
>98% |
1 G |
7200 |
chiralix |
CX13425-5G |
D-azidoserine tert-butyl ether CHA salt |
cyclohexanaminium (R)-2-azido-3-tert-butoxypropanoate |
Not available |
286.37 |
C13 H26 N4 O3 |
N3-D-Ser(OtBu)-OH · CHA |
>98% |
5 G |
27200 |
chiralix |
CX29937-1G |
D-azidothreonine tert-butyl ether CHA salt |
cyclohexanaminium (2R,3S)-2-azido-3-tert-butoxybutanoate |
Not available |
300.40 |
C14 H28 N4 O3 |
N3-D-Thr(OtBu)-OH · CHA |
>98% |
1 G |
6400 |
chiralix |
CX29937-5G |
D-azidothreonine tert-butyl ether CHA salt |
cyclohexanaminium (2R,3S)-2-azido-3-tert-butoxybutanoate |
Not available |
300.40 |
C14 H28 N4 O3 |
N3-D-Thr(OtBu)-OH · CHA |
>98% |
5 G |
24200 |
chiralix |
CX85233-1G |
L-azidothreonine CHA salt |
cyclohexanaminium (2S,3R)-2-azido-3-hydroxybutanoate |
Not available |
244.29 |
C10 H20 N4 O3 |
N3-Thr-OH · CHA |
>98% |
1 G |
2600 |
chiralix |
CX85233-5G |
L-azidothreonine CHA salt |
cyclohexanaminium (2S,3R)-2-azido-3-hydroxybutanoate |
Not available |
244.29 |
C10 H20 N4 O3 |
N3-Thr-OH · CHA |
>98% |
5 G |
9800 |
chiralix |
CX37313-1G |
D-azidothreonine CHA salt |
cyclohexanaminium (2R,3S)-2-azido-3-hydroxybutanoate |
Not available |
244.29 |
C10 H20 N4 O3 |
N3-D-Thr-OH · CHA |
>98% |
1 G |
3000 |
chiralix |
CX37313-5G |
D-azidothreonine CHA salt |
cyclohexanaminium (2R,3S)-2-azido-3-hydroxybutanoate |
Not available |
244.29 |
C10 H20 N4 O3 |
N3-D-Thr-OH · CHA |
>98% |
5 G |
11200 |
chiralix |
CX95405-1G |
D-azidoserine CHA salt |
cyclohexanaminium (R)-2-azido-3-hydroxypropanoate |
Not available |
230.26 |
C9 H18 N4 O3 |
N3-D-Ser-OH · CHA |
>98% |
1 G |
3200 |
chiralix |
CX95405-5G |
D-azidoserine CHA salt |
cyclohexanaminium (R)-2-azido-3-hydroxypropanoate |
Not available |
230.26 |
C9 H18 N4 O3 |
N3-D-Ser-OH · CHA |
>98% |
5 G |
12000 |
chiralix |
CX57717-1G |
L-azidoglutamine DCHA salt |
dicyclohexylammonium (S)-5-amino-2-azido-5-oxopentanoate |
Not available |
353.46 |
C17 H31 N5 O3 |
N3-Gln-OH · DCHA |
>98% |
1 G |
2600 |
chiralix |
CX57717-5G |
L-azidoglutamine DCHA salt |
dicyclohexylammonium (S)-5-amino-2-azido-5-oxopentanoate |
Not available |
353.46 |
C17 H31 N5 O3 |
N3-Gln-OH · DCHA |
>98% |
5 G |
9800 |
chiralix |
CX79807-1G |
D-azidoglutamine DCHA salt |
dicyclohexylammonium (R)-5-amino-2-azido-5-oxopentanoate |
Not available |
353.46 |
C17 H31 N5 O3 |
N3-D-Gln-OH · DCHA |
>98% |
1 G |
3200 |
chiralix |
CX79807-5G |
D-azidoglutamine DCHA salt |
dicyclohexylammonium (R)-5-amino-2-azido-5-oxopentanoate |
Not available |
353.46 |
C17 H31 N5 O3 |
N3-D-Gln-OH · DCHA |
>98% |
5 G |
12000 |
chiralix |
CX94556-1G |
L-azidoasparagine DCHA salt |
dicyclohexylammonium (S)-4-amino-2-azido-4-oxobutanoate |
79410-49-4 |
339.43 |
C16 H29 N5 O3 |
N3-Asn-OH · DCHA |
>98% |
1 G |
3200 |
chiralix |
CX94556-5G |
L-azidoasparagine DCHA salt |
dicyclohexylammonium (S)-4-amino-2-azido-4-oxobutanoate |
79410-49-4 |
339.43 |
C16 H29 N5 O3 |
N3-Asn-OH · DCHA |
>98% |
5 G |
12000 |
chiralix |
CX83100-1G |
D-azidoasparagine DCHA salt |
dicyclohexylammonium (R)-4-amino-2-azido-4-oxobutanoate |
Not available |
339.43 |
C16 H29 N5 O3 |
N3-D-Asn-OH · DCHA |
>98% |
1 G |
4000 |
chiralix |
CX83100-5G |
D-azidoasparagine DCHA salt |
dicyclohexylammonium (R)-4-amino-2-azido-4-oxobutanoate |
Not available |
339.43 |
C16 H29 N5 O3 |
N3-D-Asn-OH · DCHA |
>98% |
5 G |
15000 |
chiralix |
CX48141-1G |
D-azidotryptophan CHA salt |
cyclohexanaminium (R)-2-azido-3-(1H-indol-2-yl)propanoate |
Not available |
329.40 |
C17 H23 N5 O2 |
N3-D-Trp-OH · CHA |
>98% |
1 G |
2600 |
chiralix |
CX48141-5G |
D-azidotryptophan CHA salt |
cyclohexanaminium (R)-2-azido-3-(1H-indol-2-yl)propanoate |
Not available |
329.40 |
C17 H23 N5 O2 |
N3-D-Trp-OH · CHA |
>98% |
5 G |
9800 |
chiralix |
CX93426-1G |
N-im-trityl-L-azidohistidine CHA salt |
cyclohexanaminium (S)-2-azido-3-(1-trityl-1H-imidazol-4-yl)propanoate |
Not available |
522.64 |
C31 H34 N6 O2 |
N3-His(Trt)-OH · CHA |
>98% |
1 G |
4000 |
chiralix |
CX93426-5G |
N-im-trityl-L-azidohistidine CHA salt |
cyclohexanaminium (S)-2-azido-3-(1-trityl-1H-imidazol-4-yl)propanoate |
Not available |
522.64 |
C31 H34 N6 O2 |
N3-His(Trt)-OH · CHA |
>98% |
5 G |
15000 |
chiralix |
CX24279-1G |
D-azidotyrosine CHA salt |
cyclohexanaminium (R)-2-azido-3-(4-hydroxyphenyl)propanoate |
Not available |
306.36 |
C15 H22 N4 O3 |
N3-D-Tyr-OH · CHA |
>98% |
1 G |
3600 |
chiralix |
CX24279-5G |
D-azidotyrosine CHA salt |
cyclohexanaminium (R)-2-azido-3-(4-hydroxyphenyl)propanoate |
Not available |
306.36 |
C15 H22 N4 O3 |
N3-D-Tyr-OH · CHA |
>98% |
5 G |
13600 |
chiralix |
CX78063-1G |
L-azido-tert-leucine CHA salt |
cyclohexanaminium (S)-2-azido-3,3-dimethylbutanoate |
Not available |
256.34 |
C12 H24 N4 O2 |
N3-tert-Leu-OH · CHA |
>98% |
1 G |
2800 |
chiralix |
CX78063-5G |
L-azido-tert-leucine CHA salt |
cyclohexanaminium (S)-2-azido-3,3-dimethylbutanoate |
Not available |
256.34 |
C12 H24 N4 O2 |
N3-tert-Leu-OH · CHA |
>98% |
5 G |
10600 |
chiralix |
CX30547-1G |
D-azido-tert-leucine CHA salt |
cyclohexanaminium (R)-2-azido-3,3-dimethylbutanoate |
Not available |
256.34 |
C12 H24 N4 O2 |
N3-D-tert-Leu-OH · CHA |
>98% |
1 G |
6600 |
chiralix |
CX30547-5G |
D-azido-tert-leucine CHA salt |
cyclohexanaminium (R)-2-azido-3,3-dimethylbutanoate |
Not available |
256.34 |
C12 H24 N4 O2 |
N3-D-tert-Leu-OH · CHA |
>98% |
5 G |
25000 |
chiralix |
CX78942-1G |
L-azidoallylglycine CHA salt |
cyclohexanaminium (S)-2-azidopent-4-enoate |
Not available |
240.30 |
C11 H20 N4 O2 |
N3-Alg-OH · CHA |
>98% |
1 G |
5600 |
chiralix |
CX78942-5G |
L-azidoallylglycine CHA salt |
cyclohexanaminium (S)-2-azidopent-4-enoate |
Not available |
240.30 |
C11 H20 N4 O2 |
N3-Alg-OH · CHA |
>98% |
5 G |
21200 |
chiralix |
CX61332-1G |
D-azidoallylglycine CHA salt |
cyclohexanaminium (R)-2-azidopent-4-enoate |
Not available |
240.30 |
C11 H20 N4 O2 |
N3-D-Alg-OH · CHA |
>98% |
1 G |
9000 |
chiralix |
CX61332-2G |
D-azidoallylglycine CHA salt |
cyclohexanaminium (R)-2-azidopent-4-enoate |
Not available |
240.30 |
C11 H20 N4 O2 |
N3-D-Alg-OH · CHA |
>98% |
2 G |
16000 |
chiralix |
CX56925-1G |
Ng-Pmc-L-azidoarginine |
(S)-2-azido-5-(3-(2,2,5,7,8-pentamethylchroman-6-ylsulfonyl)guanidino)pentanoic acid |
Not available |
466.55 |
C20 H30 N6 O5 S |
Ng-2,2,5,7,8-pentamethylchroman-6-sulfonyl-L-azidoarginine |
>95% |
1 G |
4000 |
chiralix |
CX56925-5G |
Ng-Pmc-L-azidoarginine |
(S)-2-azido-5-(3-(2,2,5,7,8-pentamethylchroman-6-ylsulfonyl)guanidino)pentanoic acid |
Not available |
466.55 |
C20 H30 N6 O5 S |
Ng-2,2,5,7,8-pentamethylchroman-6-sulfonyl-L-azidoarginine |
>95% |
5 G |
15000 |
chiralix |
CX22361-1G |
(S)-azido-alpha-methyl-phenylglycine CHA salt |
cyclohexanaminium (S)-2-azido-2-phenylpropanoate |
Not available |
290.36 |
C15 H22 N4 O2 |
(S)-N3-Mpg-OH · CHA |
>98% |
1 G |
9000 |
chiralix |
CX22361-2G |
(S)-azido-alpha-methyl-phenylglycine CHA salt |
cyclohexanaminium (S)-2-azido-2-phenylpropanoate |
Not available |
290.36 |
C15 H22 N4 O2 |
(S)-N3-Mpg-OH · CHA |
>98% |
2 G |
14800 |
chiralix |
CX52265-1G |
(R)-azido-alpha-methylphenylglycine CHA salt |
cyclohexanaminium (R)-2-azido-2-phenylpropanoate |
Not available |
290.36 |
C15 H22 N4 O2 |
(R)-N3-Mpg-OH · CHA |
>98% |
1 G |
10400 |
chiralix |
CX52265-2G |
(R)-azido-alpha-methylphenylglycine CHA salt |
cyclohexanaminium (R)-2-azido-2-phenylpropanoate |
Not available |
290.36 |
C15 H22 N4 O2 |
(R)-N3-Mpg-OH · CHA |
>98% |
2 G |
17200 |
chiralix |
CX71813-1G |
S-Trityl-L-azidocysteine CHA salt |
cyclohexanaminium (R)-2-azido-3-(tritylthio)propanoate |
Not available |
488.64 |
C28 H32 N4 O2 S |
N3-Cys(Trt)-OH · CHA |
>98% |
1 G |
3000 |
chiralix |
CX71813-5G |
S-Trityl-L-azidocysteine CHA salt |
cyclohexanaminium (R)-2-azido-3-(tritylthio)propanoate |
Not available |
488.64 |
C28 H32 N4 O2 S |
N3-Cys(Trt)-OH · CHA |
>98% |
5 G |
11200 |
chiralix |
CX40608-5G |
6-azidohexanoic acid |
6-azidohexanoic acid |
79598-53-1 |
157.17 |
C6 H11 N3 O2 |
|
>98% |
5 G |
6000 |
chiralix |
CX40608-10G |
6-azidohexanoic acid |
6-azidohexanoic acid |
79598-53-1 |
157.17 |
C6 H11 N3 O2 |
|
>98% |
10 G |
11000 |
chiralix |
CX23053-500MG |
(S)-bishomopropargylglycinol hydrochloride |
(S)-2-aminohept-6-yn-1-ol hydrochloride |
Not available |
163.65 |
C7 H14 Cl N O |
|
>98% |
500 MG |
10400 |
chiralix |
CX23053-1G |
(S)-bishomopropargylglycinol hydrochloride |
(S)-2-aminohept-6-yn-1-ol hydrochloride |
Not available |
163.65 |
C7 H14 Cl N O |
|
>98% |
1 G |
17200 |
chiralix |
CX63523-500MG |
(R)-bishomopropargylglycinol hydrochloride |
(R)-2-aminohept-6-yn-1-ol hydrochloride |
Not available |
163.65 |
C7 H14 Cl N O |
|
>98% |
500 MG |
10400 |
chiralix |
CX63523-1G |
(R)-bishomopropargylglycinol hydrochloride |
(R)-2-aminohept-6-yn-1-ol hydrochloride |
Not available |
163.65 |
C7 H14 Cl N O |
|
>98% |
1 G |
17200 |
chiralix |
CX69091-500MG |
(R)-homopropargylglycinol hydrochloride |
(R)-2-aminohex-5-yn-1-ol hydrochloride |
Not available |
149.62 |
C6 H12 Cl N O |
|
>98% |
500 MG |
11000 |
chiralix |
CX69091-1G |
(R)-homopropargylglycinol hydrochloride |
(R)-2-aminohex-5-yn-1-ol hydrochloride |
Not available |
149.62 |
C6 H12 Cl N O |
|
>98% |
1 G |
17800 |
chiralix |
CX76358-500MG |
(S)-homopropargylglycinol hydrochloride |
(S)-2-aminohex-5-yn-1-ol hydrochloride |
Not available |
149.62 |
C6 H12 Cl N O |
|
>98% |
500 MG |
11000 |
chiralix |
CX76358-1G |
(S)-homopropargylglycinol hydrochloride |
(S)-2-aminohex-5-yn-1-ol hydrochloride |
Not available |
149.62 |
C6 H12 Cl N O |
|
>98% |
1 G |
17800 |
chiralix |
CX55029-2MG |
cereulide |
cyclo[-Val-D-O-Leu-D-Ala-O-Val-]3 |
Not available |
1153.40 |
C57 H96 N6 O18 |
|
>95% |
2 MG |
12000 |
chiralix |
CX55029-5MG |
cereulide |
cyclo[-Val-D-O-Leu-D-Ala-O-Val-]3 |
Not available |
1153.40 |
C57 H96 N6 O18 |
|
>95% |
5 MG |
24000 |
chiralix |
CX45120-1G |
H-Orn(Boc)-pNA |
(S)-tert-butyl (4-amino-5-((4-nitrophenyl)amino)-5-oxopentyl)carbamate |
Not available |
352.39 |
C16 H24 N4 O5 |
|
>98% |
1 G |
4000 |
chiralix |
CX45120-2G |
H-Orn(Boc)-pNA |
(S)-tert-butyl (4-amino-5-((4-nitrophenyl)amino)-5-oxopentyl)carbamate |
Not available |
352.39 |
C16 H24 N4 O5 |
|
>98% |
2 G |
9000 |
chiralix |
CX45120-5G |
H-Orn(Boc)-pNA |
(S)-tert-butyl (4-amino-5-((4-nitrophenyl)amino)-5-oxopentyl)carbamate |
Not available |
352.39 |
C16 H24 N4 O5 |
|
>98% |
5 G |
15000 |
chiralix |
CX57163-2MG |
13C6-cereulide |
cyclo[-Val-1-13C-D-O-Leu-D-Ala-3-13C-O-Val-]3 |
Not available |
1159.36 |
C51 13 C6 H96 N6 O18 |
|
>95% |
2 MG |
24000 |
chiralix |
CX64158-1G |
Fmoc-Orn-pNA · HCl |
(S)-(9H-fluoren-9-yl)methyl (5-ami-((4-nitrophenyl)amino)-1-oxopentan-2-yl)carbamate hydrochloride |
Not available |
510.97 |
C26 H27 Cl N4 O5 |
Fmoc-Orn-pNA HCl salt |
>98% |
1 G |
4000 |
chiralix |
CX64158-2G |
Fmoc-Orn-pNA · HCl |
(S)-(9H-fluoren-9-yl)methyl (5-ami-((4-nitrophenyl)amino)-1-oxopentan-2-yl)carbamate hydrochloride |
Not available |
510.97 |
C26 H27 Cl N4 O5 |
Fmoc-Orn-pNA HCl salt |
>98% |
2 G |
7200 |
chiralix |
CX64158-5G |
Fmoc-Orn-pNA · HCl |
(S)-(9H-fluoren-9-yl)methyl (5-ami-((4-nitrophenyl)amino)-1-oxopentan-2-yl)carbamate hydrochloride |
Not available |
510.97 |
C26 H27 Cl N4 O5 |
Fmoc-Orn-pNA HCl salt |
>98% |
5 G |
15000 |
chiralix |
CX80044-250MG |
Bis(H-Orn(Boc))-rhodamine 110 |
Bis(H-Orn(Boc))-rhodamine |
Not available |
758.86 |
C40 H50 N6 O9 |
|
>95% |
250 MG |
7600 |
chiralix |
CX80044-500MG |
Bis(H-Orn(Boc))-rhodamine 110 |
Bis(H-Orn(Boc))-rhodamine |
Not available |
758.86 |
C40 H50 N6 O9 |
|
>95% |
500 MG |
14000 |
chiralix |
CX80044-1G |
Bis(H-Orn(Boc))-rhodamine 110 |
Bis(H-Orn(Boc))-rhodamine |
Not available |
758.86 |
C40 H50 N6 O9 |
|
>95% |
1 G |
25000 |
chiralix |
CX67830-250MG |
Bis(H-Arg(Boc)2)-rhodamine 110 |
Bis(H-Arg(Boc)2)-rhodamine |
Not available |
1043.17 |
C52 H70 N10 O13 |
|
>95% |
250 MG |
7800 |
chiralix |
CX67830-500MG |
Bis(H-Arg(Boc)2)-rhodamine 110 |
Bis(H-Arg(Boc)2)-rhodamine |
Not available |
1043.17 |
C52 H70 N10 O13 |
|
>95% |
500 MG |
14400 |
chiralix |
CX67830-1G |
Bis(H-Arg(Boc)2)-rhodamine 110 |
Bis(H-Arg(Boc)2)-rhodamine |
Not available |
1043.17 |
C52 H70 N10 O13 |
|
>95% |
1 G |
26000 |
chiralix |
CX18326-1G |
Fmoc-Orn-AMC · HCl |
(S)-(9H-fluoren-9-yl)methyl (5-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)carbamate hydrochloride |
Not available |
548.03 |
C30 H30 Cl N3 O5 |
|
>98% |
1 G |
5000 |
chiralix |
CX18326-2G |
Fmoc-Orn-AMC · HCl |
(S)-(9H-fluoren-9-yl)methyl (5-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)carbamate hydrochloride |
Not available |
548.03 |
C30 H30 Cl N3 O5 |
|
>98% |
2 G |
9000 |
chiralix |
CX18326-5G |
Fmoc-Orn-AMC · HCl |
(S)-(9H-fluoren-9-yl)methyl (5-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)carbamate hydrochloride |
Not available |
548.03 |
C30 H30 Cl N3 O5 |
|
>98% |
5 G |
19000 |
chiralix |
CX59077-1G |
H-Orn(Boc)-AMC |
(S)-tert-butyl (4-amino-5-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-5-oxopentyl)carbamate |
Not available |
389.45 |
C20 H27 N3 O5 |
|
>98% |
1 G |
6000 |
chiralix |
CX59077-2G |
H-Orn(Boc)-AMC |
(S)-tert-butyl (4-amino-5-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-5-oxopentyl)carbamate |
Not available |
389.45 |
C20 H27 N3 O5 |
|
>98% |
2 G |
10800 |
chiralix |
CX59077-5G |
H-Orn(Boc)-AMC |
(S)-tert-butyl (4-amino-5-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-5-oxopentyl)carbamate |
Not available |
389.45 |
C20 H27 N3 O5 |
|
>98% |
5 G |
22000 |
chiralix |
CX48623-1G |
H-Lys(Boc)-AMC |
(S)-tert-butyl (5-amino-6-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-6-oxohexyl)carbamate |
222037-62-9 |
403.47 |
C21 H29 N3 O5 |
|
>98% |
1 G |
5000 |
chiralix |
CX48623-2G |
H-Lys(Boc)-AMC |
(S)-tert-butyl (5-amino-6-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-6-oxohexyl)carbamate |
222037-62-9 |
403.47 |
C21 H29 N3 O5 |
|
>98% |
2 G |
9000 |
chiralix |
CX48623-5G |
H-Lys(Boc)-AMC |
(S)-tert-butyl (5-amino-6-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-6-oxohexyl)carbamate |
222037-62-9 |
403.47 |
C21 H29 N3 O5 |
|
>98% |
5 G |
19000 |
chiralix |
CX55361-500MG |
H-Arg(Boc)2-AMC |
H-Arg(Boc)2-AMC |
Not available |
531.60 |
C26 H37 N5 O7 |
|
>97% |
500 MG |
6000 |
chiralix |
CX55361-1G |
H-Arg(Boc)2-AMC |
H-Arg(Boc)2-AMC |
Not available |
531.60 |
C26 H37 N5 O7 |
|
>97% |
1 G |
10800 |
chiralix |
CX84944-1G |
Fmoc-Lys-AMC · HCl |
(S)-(9H-fluoren-9-yl)methyl (6-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamate hydrochloride |
Not available |
562.06 |
C31 H32 Cl N3 O5 |
|
>98% |
1 G |
4000 |
chiralix |
CX84944-2G |
Fmoc-Lys-AMC · HCl |
(S)-(9H-fluoren-9-yl)methyl (6-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamate hydrochloride |
Not available |
562.06 |
C31 H32 Cl N3 O5 |
|
>98% |
2 G |
7200 |
chiralix |
CX84944-5G |
Fmoc-Lys-AMC · HCl |
(S)-(9H-fluoren-9-yl)methyl (6-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamate hydrochloride |
Not available |
562.06 |
C31 H32 Cl N3 O5 |
|
>98% |
5 G |
15000 |
chiralix |
CX69359-5G |
4-azidobutyric acid |
4-azidobutanoic acid |
54447-68-6 |
129.12 |
C4 H7 N3 O2 |
gamma-azidobutyric acid |
>98% |
5 G |
6000 |
chiralix |
CX69359-10G |
4-azidobutyric acid |
4-azidobutanoic acid |
54447-68-6 |
129.12 |
C4 H7 N3 O2 |
gamma-azidobutyric acid |
>98% |
10 G |
11000 |
chiralix |
CX31309-5G |
5-azidovaleric acid |
5-azidopentanoic acid |
79583-98-5 |
143.14 |
C5 H9 N3 O2 |
delta-azidovaleric acid |
>98% |
5 G |
6600 |
chiralix |
CX31309-10G |
5-azidovaleric acid |
5-azidopentanoic acid |
79583-98-5 |
143.14 |
C5 H9 N3 O2 |
delta-azidovaleric acid |
>98% |
10 G |
11800 |
chiralix |
CX98490-5G |
7-azidoheptanoic acid |
7-azidoheptanoic acid |
135920-28-4 |
171.20 |
C7 H13 N3 O2 |
|
>98% |
5 G |
6000 |
chiralix |
CX98490-10G |
7-azidoheptanoic acid |
7-azidoheptanoic acid |
135920-28-4 |
171.20 |
C7 H13 N3 O2 |
|
>98% |
10 G |
11000 |
chiralix |
CX65527-1G |
6-methylcyclohex-1-enecarboxylic acid |
6-methylcyclohex-1-enecarboxylic acid |
5726-56-7 |
140.18 |
C8 H12 O2 |
|
>98% |
1 G |
2800 |
chiralix |
CX65527-5G |
6-methylcyclohex-1-enecarboxylic acid |
6-methylcyclohex-1-enecarboxylic acid |
5726-56-7 |
140.18 |
C8 H12 O2 |
|
>98% |
5 G |
10600 |
chiralix |
CX65527-10G |
6-methylcyclohex-1-enecarboxylic acid |
6-methylcyclohex-1-enecarboxylic acid |
5726-56-7 |
140.18 |
C8 H12 O2 |
|
>98% |
10 G |
17000 |
chiralix |
CX61074-200MG |
(S)-beta2-homoalanine HCl salt |
(S)-3-amino-2-methylpropanoic acid hydrochloride |
Not available |
139.58 |
C4 H10 Cl N O2 |
(S)-beta2-hAla-OH · HCl |
>98% |
200 MG |
4800 |
chiralix |
CX61074-500MG |
(S)-beta2-homoalanine HCl salt |
(S)-3-amino-2-methylpropanoic acid hydrochloride |
Not available |
139.58 |
C4 H10 Cl N O2 |
(S)-beta2-hAla-OH · HCl |
>98% |
500 MG |
9800 |
chiralix |
CX61074-1G |
(S)-beta2-homoalanine HCl salt |
(S)-3-amino-2-methylpropanoic acid hydrochloride |
Not available |
139.58 |
C4 H10 Cl N O2 |
(S)-beta2-hAla-OH · HCl |
>98% |
1 G |
16000 |
chiralix |
CX39389-200MG |
(R)-beta2-homoalanine HCl salt |
(R)-3-amino-2-methylpropanoic acid hydrochloride |
Not available |
139.58 |
C4 H10 Cl N O2 |
(R)-beta2-hAla-OH · HCl |
>98% |
200 MG |
4800 |
chiralix |
CX39389-500MG |
(R)-beta2-homoalanine HCl salt |
(R)-3-amino-2-methylpropanoic acid hydrochloride |
Not available |
139.58 |
C4 H10 Cl N O2 |
(R)-beta2-hAla-OH · HCl |
>98% |
500 MG |
9800 |
chiralix |
CX39389-1G |
(R)-beta2-homoalanine HCl salt |
(R)-3-amino-2-methylpropanoic acid hydrochloride |
Not available |
139.58 |
C4 H10 Cl N O2 |
(R)-beta2-hAla-OH · HCl |
>98% |
1 G |
16000 |
chiralix |
CX80391-200MG |
(R)-beta2-homoleucine HCl salt |
(R)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride |
Not available |
181.66 |
C7 H16 Cl N O2 |
(R)-beta2-hLeu-OH · HCl |
>98% |
200 MG |
4800 |
chiralix |
CX80391-500MG |
(R)-beta2-homoleucine HCl salt |
(R)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride |
Not available |
181.66 |
C7 H16 Cl N O2 |
(R)-beta2-hLeu-OH · HCl |
>98% |
500 MG |
9800 |
chiralix |
CX80391-1G |
(R)-beta2-homoleucine HCl salt |
(R)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride |
Not available |
181.66 |
C7 H16 Cl N O2 |
(R)-beta2-hLeu-OH · HCl |
>98% |
1 G |
16000 |
chiralix |
CX82876-200MG |
(R)-beta2-homovaline HCl salt |
(R)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride |
Not available |
167.63 |
C6 H14 Cl N O2 |
(R)-beta2-hVal-OH · HCl |
>98% |
200 MG |
4800 |
chiralix |
CX82876-500MG |
(R)-beta2-homovaline HCl salt |
(R)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride |
Not available |
167.63 |
C6 H14 Cl N O2 |
(R)-beta2-hVal-OH · HCl |
>98% |
500 MG |
9800 |
chiralix |
CX82876-1G |
(R)-beta2-homovaline HCl salt |
(R)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride |
Not available |
167.63 |
C6 H14 Cl N O2 |
(R)-beta2-hVal-OH · HCl |
>98% |
1 G |
16000 |
chiralix |
CX93488-1MG |
(±)-sorgolactone |
(3aR*,8S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-8-methyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one |
Not available |
316.35 |
C18 H20 O5 |
racemic sorgolactone |
>98% |
1 MG |
4000 |
chiralix |
CX93488-5MG |
(±)-sorgolactone |
(3aR*,8S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-8-methyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one |
Not available |
316.35 |
C18 H20 O5 |
racemic sorgolactone |
>98% |
5 MG |
15000 |
chiralix |
CX64382-1MG |
(±)-strigol |
(3aR*,5S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-5-hydroxy-8,8-dimethyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one |
51820-11-2 |
346.37 |
C19 H22 O6 |
|
>98% |
1 MG |
5000 |
chiralix |
CX64382-5MG |
(±)-strigol |
(3aR*,5S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-5-hydroxy-8,8-dimethyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one |
51820-11-2 |
346.37 |
C19 H22 O6 |
|
>98% |
5 MG |
18800 |
chiralix |
CX88057-10MG |
Nijmegen-1 |
(Z)-methyl 2-(1,3-dioxoisoindolin-2-yl)-3-((4-methyl-5-oxo-2,5-dihydrofuran-2-yl)oxy)acrylate |
159155-03-0 |
343.29 |
C17 H13 N O7 |
|
>98% |
10 MG |
3600 |
chiralix |
CX88057-50MG |
Nijmegen-1 |
(Z)-methyl 2-(1,3-dioxoisoindolin-2-yl)-3-((4-methyl-5-oxo-2,5-dihydrofuran-2-yl)oxy)acrylate |
159155-03-0 |
343.29 |
C17 H13 N O7 |
|
>98% |
50 MG |
11800 |
chiralix |
CX42450-200MG |
(S)-beta2-homophenylalanine HCl salt |
(S)-3-amino-2-benzylpropanoic acid hydrochloride |
1010806-95-7 |
215.68 |
C10 H14 Cl N O2 |
(S)-beta2-hPhe-OH · HCl |
>98% |
200 MG |
4800 |
chiralix |
CX42450-500MG |
(S)-beta2-homophenylalanine HCl salt |
(S)-3-amino-2-benzylpropanoic acid hydrochloride |
1010806-95-7 |
215.68 |
C10 H14 Cl N O2 |
(S)-beta2-hPhe-OH · HCl |
>98% |
500 MG |
9800 |
chiralix |
CX42450-1G |
(S)-beta2-homophenylalanine HCl salt |
(S)-3-amino-2-benzylpropanoic acid hydrochloride |
1010806-95-7 |
215.68 |
C10 H14 Cl N O2 |
(S)-beta2-hPhe-OH · HCl |
>98% |
1 G |
16000 |
chiralix |
CX35419-200MG |
(S)-beta2-homovaline HCl salt |
(S)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride |
Not available |
167.63 |
C6 H14 Cl N O2 |
(S)-beta2-hVal-OH · HCl |
>98% |
200 MG |
4800 |
chiralix |
CX35419-500MG |
(S)-beta2-homovaline HCl salt |
(S)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride |
Not available |
167.63 |
C6 H14 Cl N O2 |
(S)-beta2-hVal-OH · HCl |
>98% |
500 MG |
9800 |
chiralix |
CX35419-1G |
(S)-beta2-homovaline HCl salt |
(S)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride |
Not available |
167.63 |
C6 H14 Cl N O2 |
(S)-beta2-hVal-OH · HCl |
>98% |
1 G |
16000 |
chiralix |
CX11583-200MG |
(R)-beta2-homophenylalanine HCl salt |
(R)-3-amino-2-benzylpropanoic acid hydrochloride |
Not available |
215.68 |
C10 H14 Cl N O2 |
(R)-beta2-hPhe-OH · HCl |
>98% |
200 MG |
4800 |
chiralix |
CX11583-500MG |
(R)-beta2-homophenylalanine HCl salt |
(R)-3-amino-2-benzylpropanoic acid hydrochloride |
Not available |
215.68 |
C10 H14 Cl N O2 |
(R)-beta2-hPhe-OH · HCl |
>98% |
500 MG |
9800 |
chiralix |
CX11583-1G |
(R)-beta2-homophenylalanine HCl salt |
(R)-3-amino-2-benzylpropanoic acid hydrochloride |
Not available |
215.68 |
C10 H14 Cl N O2 |
(R)-beta2-hPhe-OH · HCl |
>98% |
1 G |
16000 |
chiralix |
CX92224-200MG |
(S)-beta2-homoleucine HCl salt |
(S)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride |
Not available |
181.66 |
C7 H16 Cl N O2 |
(S)-beta2-hLeu-OH · HCl |
>98% |
200 MG |
4800 |
chiralix |
CX92224-500MG |
(S)-beta2-homoleucine HCl salt |
(S)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride |
Not available |
181.66 |
C7 H16 Cl N O2 |
(S)-beta2-hLeu-OH · HCl |
>98% |
500 MG |
9800 |
chiralix |
CX92224-1G |
(S)-beta2-homoleucine HCl salt |
(S)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride |
Not available |
181.66 |
C7 H16 Cl N O2 |
(S)-beta2-hLeu-OH · HCl |
>98% |
1 G |
16000 |
chiralix |
CX81018-500MG |
(S)-Fmoc-beta2-homoalanine |
(S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoic acid |
203854-58-4 |
325.36 |
C19 H19 N O4 |
(S)-Fmoc-beta2-hAla-OH |
>98% |
500 MG |
11200 |
chiralix |
CX81018-1G |
(S)-Fmoc-beta2-homoalanine |
(S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoic acid |
203854-58-4 |
325.36 |
C19 H19 N O4 |
(S)-Fmoc-beta2-hAla-OH |
>98% |
1 G |
18400 |
chiralix |
CX85919-500MG |
(R)-Fmoc-beta2-homoalanine |
(R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoic acid |
Not available |
325.36 |
C19 H19 N O4 |
(R)-Fmoc-beta2-hAla-OH |
>98% |
500 MG |
11200 |
chiralix |
CX85919-1G |
(R)-Fmoc-beta2-homoalanine |
(R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoic acid |
Not available |
325.36 |
C19 H19 N O4 |
(R)-Fmoc-beta2-hAla-OH |
>98% |
1 G |
18400 |
chiralix |
CX98774-500MG |
(R)-Fmoc-beta2-homoleucine |
(R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoic acid |
1018899-99-4 |
367.44 |
C22 H25 N O4 |
(R)-Fmoc-beta2-hLeu-OH |
>98% |
500 MG |
11200 |
chiralix |
CX98774-1G |
(R)-Fmoc-beta2-homoleucine |
(R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoic acid |
1018899-99-4 |
367.44 |
C22 H25 N O4 |
(R)-Fmoc-beta2-hLeu-OH |
>98% |
1 G |
18400 |
chiralix |
CX33604-500MG |
(R)-Fmoc-beta2-homovaline |
(R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoic acid |
Not available |
353.41 |
C21 H23 N O4 |
(R)-Fmoc-beta2-hVal-OH |
>98% |
500 MG |
11200 |
chiralix |
CX33604-1G |
(R)-Fmoc-beta2-homovaline |
(R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoic acid |
Not available |
353.41 |
C21 H23 N O4 |
(R)-Fmoc-beta2-hVal-OH |
>98% |
1 G |
18400 |
chiralix |
CX82946-500MG |
(S)-Fmoc-beta2-homophenylalanine |
(S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid |
203854-62-0 |
401.45 |
C25 H23 N O4 |
(S)-Fmoc-beta2-hPhe-OH |
>98% |
500 MG |
11200 |
chiralix |
CX82946-1G |
(S)-Fmoc-beta2-homophenylalanine |
(S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid |
203854-62-0 |
401.45 |
C25 H23 N O4 |
(S)-Fmoc-beta2-hPhe-OH |
>98% |
1 G |
18400 |
chiralix |
CX86231-500MG |
(S)-Fmoc-beta2-homovaline |
(S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoic acid |
203854-59-5 |
353.41 |
C21 H23 N O4 |
(S)-Fmoc-beta2-hVal-OH |
>98% |
500 MG |
11200 |
chiralix |
CX86231-1G |
(S)-Fmoc-beta2-homovaline |
(S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoic acid |
203854-59-5 |
353.41 |
C21 H23 N O4 |
(S)-Fmoc-beta2-hVal-OH |
>98% |
1 G |
18400 |
chiralix |
CX15046-500MG |
(R)-Fmoc-beta2-homophenylalanine |
(R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid |
828254-16-6 |
401.45 |
C25 H23 N O4 |
(R)-Fmoc-beta2-hPhe-OH |
>98% |
500 MG |
11200 |
chiralix |
CX15046-1G |
(R)-Fmoc-beta2-homophenylalanine |
(R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid |
828254-16-6 |
401.45 |
C25 H23 N O4 |
(R)-Fmoc-beta2-hPhe-OH |
>98% |
1 G |
18400 |
chiralix |
CX30199-500MG |
(S)-Fmoc-beta2-homoleucine |
(S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoic acid |
193887-45-5 |
367.44 |
C22 H25 N O4 |
(S)-Fmoc-beta2-hLeu-OH |
>98% |
500 MG |
11200 |
chiralix |
CX30199-1G |
(S)-Fmoc-beta2-homoleucine |
(S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoic acid |
193887-45-5 |
367.44 |
C22 H25 N O4 |
(S)-Fmoc-beta2-hLeu-OH |
>98% |
1 G |
18400 |
chiralix |
CX20422-1ML |
cereulide (50 µg/mL in acetonitrile) |
cyclo[-Val-D-O-Leu-D-Ala-O-Val-]3 (50 µg/mL in acetonitrile) |
Not available |
1153.40 |
C57 H96 N6 O18 |
cereulide stock solution |
>95% |
1 ML |
5000 |
chiralix |
CX87778-1ML |
13C6-cereulide (20 µg/mL in acetonitrile) |
cyclo[-Val-1-13C-D-O-Leu-D-Ala-3-13C-O-Val-]3 (20 µg/mL in acetonitrile) |
Not available |
1159.36 |
C51 13 C6 H96 N6 O18 |
13C6-cereulide stock solution |
>95% |
1 ML |
5000 |
chiralix |
CX18112-1G |
4-(azidomethyl)benzoic acid |
4-(azidomethyl)benzoic acid |
79584-03-5 |
177.16 |
C8 H7 N3 O2 |
|
>98% |
1 G |
3000 |
chiralix |
CX18112-5G |
4-(azidomethyl)benzoic acid |
4-(azidomethyl)benzoic acid |
79584-03-5 |
177.16 |
C8 H7 N3 O2 |
|
>98% |
5 G |
7400 |
chiralix |
CX18112-10G |
4-(azidomethyl)benzoic acid |
4-(azidomethyl)benzoic acid |
79584-03-5 |
177.16 |
C8 H7 N3 O2 |
|
>98% |
10 G |
13200 |
chiralix |
CX95981-5G |
2,2,2-trichloroethoxysulfonyl chloride |
2,2,2-trichloroethoxysulfonyl chloride |
764-09-0 |
247.91 |
C2 H2 Cl4 O2 S |
chlorosulfuric acid 2,2,2-trichloroethyl ester |
>98% |
5 G |
2200 |
chiralix |
CX95981-10G |
2,2,2-trichloroethoxysulfonyl chloride |
2,2,2-trichloroethoxysulfonyl chloride |
764-09-0 |
247.91 |
C2 H2 Cl4 O2 S |
chlorosulfuric acid 2,2,2-trichloroethyl ester |
>98% |
10 G |
4000 |
chiralix |
CX95981-25G |
2,2,2-trichloroethoxysulfonyl chloride |
2,2,2-trichloroethoxysulfonyl chloride |
764-09-0 |
247.91 |
C2 H2 Cl4 O2 S |
chlorosulfuric acid 2,2,2-trichloroethyl ester |
>98% |
25 G |
8400 |
chiralix |
CX62483-1G |
2-(azidomethyl)benzoic acid |
2-(azidomethyl)benzoic acid |
289712-57-8 |
177.16 |
C8 H7 N3 O2 |
|
>98% |
1 G |
4200 |
chiralix |
CX62483-2G |
2-(azidomethyl)benzoic acid |
2-(azidomethyl)benzoic acid |
289712-57-8 |
177.16 |
C8 H7 N3 O2 |
|
>98% |
2 G |
7600 |
chiralix |
CX62483-5G |
2-(azidomethyl)benzoic acid |
2-(azidomethyl)benzoic acid |
289712-57-8 |
177.16 |
C8 H7 N3 O2 |
|
>98% |
5 G |
16000 |
chiralix |
CX80461-1G |
3-(azidomethyl)benzoic acid |
3-(azidomethyl)benzoic acid |
905973-32-2 |
177.16 |
C8 H7 N3 O2 |
|
>98% |
1 G |
4200 |
chiralix |
CX80461-2G |
3-(azidomethyl)benzoic acid |
3-(azidomethyl)benzoic acid |
905973-32-2 |
177.16 |
C8 H7 N3 O2 |
|
>98% |
2 G |
7600 |
chiralix |
CX80461-5G |
3-(azidomethyl)benzoic acid |
3-(azidomethyl)benzoic acid |
905973-32-2 |
177.16 |
C8 H7 N3 O2 |
|
>98% |
5 G |
16000 |
chiralix |
CX27597-1G |
2,3-dimethyl-1-(2,2,2-trichloroethoxysulfuryl)imidazolium triflate |
2,3-dimethyl-1-((2,2,2-trichloroethoxy)sulfonyl)-1H-imidazol-3-ium trifluoromethanesulfonate |
1185733-70-3 |
457.66 |
C8 H10 Cl3 F3 N2 O6 S2 |
|
>98% |
1 G |
2600 |
chiralix |
CX27597-5G |
2,3-dimethyl-1-(2,2,2-trichloroethoxysulfuryl)imidazolium triflate |
2,3-dimethyl-1-((2,2,2-trichloroethoxy)sulfonyl)-1H-imidazol-3-ium trifluoromethanesulfonate |
1185733-70-3 |
457.66 |
C8 H10 Cl3 F3 N2 O6 S2 |
|
>98% |
5 G |
9800 |
chiralix |
CX50506-10MG |
TIS108 |
6-phenoxy-1-phenyl-2-(1H-1,2,4-triazol-1-yl)hexan-1-one |
Not available |
335.40 |
C20 H21 N3 O2 |
|
>98% |
10 MG |
3600 |
chiralix |
CX50506-50MG |
TIS108 |
6-phenoxy-1-phenyl-2-(1H-1,2,4-triazol-1-yl)hexan-1-one |
Not available |
335.40 |
C20 H21 N3 O2 |
|
>98% |
50 MG |
13800 |
chiralix |
CX50506-100MG |
TIS108 |
6-phenoxy-1-phenyl-2-(1H-1,2,4-triazol-1-yl)hexan-1-one |
Not available |
335.40 |
C20 H21 N3 O2 |
|
>98% |
100 MG |
23000 |
chiralix |
CX95469-10MG |
4-Br debranone |
5-(4-bromophenoxy)-3-methylfuran-2(5H)-one |
1332863-94-1 |
269.09 |
C11 H9 Br O3 |
4BD |
>98% |
10 MG |
3000 |
chiralix |
CX95469-50MG |
4-Br debranone |
5-(4-bromophenoxy)-3-methylfuran-2(5H)-one |
1332863-94-1 |
269.09 |
C11 H9 Br O3 |
4BD |
>98% |
50 MG |
11400 |
chiralix |
CX95469-100MG |
4-Br debranone |
5-(4-bromophenoxy)-3-methylfuran-2(5H)-one |
1332863-94-1 |
269.09 |
C11 H9 Br O3 |
4BD |
>98% |
100 MG |
19600 |
chiralix |
CX75854-10MG |
4-CN debranone |
5-(4-cyanophenoxy)-3-methylfuran-2(5H)-one |
1332863-97-4 |
215.20 |
C12 H9 N O3 |
|
>98% |
10 MG |
3000 |
chiralix |
CX75854-50MG |
4-CN debranone |
5-(4-cyanophenoxy)-3-methylfuran-2(5H)-one |
1332863-97-4 |
215.20 |
C12 H9 N O3 |
|
>98% |
50 MG |
11400 |
chiralix |
CX75854-100MG |
4-CN debranone |
5-(4-cyanophenoxy)-3-methylfuran-2(5H)-one |
1332863-97-4 |
215.20 |
C12 H9 N O3 |
|
>98% |
100 MG |
19600 |
chiralix |
CX52612-10MG |
Abamine oxalic acid salt |
(E)-3-(3,4-dimethoxyphenyl)-N-(4-fluorobenzyl)-N-(2-methoxy-2-oxoethyl)prop-2-en-1-aminium carboxyformate |
Not available |
463.45 |
C23 H26 F N O8 |
|
>98% |
10 MG |
3000 |
chiralix |
CX52612-50MG |
Abamine oxalic acid salt |
(E)-3-(3,4-dimethoxyphenyl)-N-(4-fluorobenzyl)-N-(2-methoxy-2-oxoethyl)prop-2-en-1-aminium carboxyformate |
Not available |
463.45 |
C23 H26 F N O8 |
|
>98% |
50 MG |
11400 |
chiralix |
CX52612-100MG |
Abamine oxalic acid salt |
(E)-3-(3,4-dimethoxyphenyl)-N-(4-fluorobenzyl)-N-(2-methoxy-2-oxoethyl)prop-2-en-1-aminium carboxyformate |
Not available |
463.45 |
C23 H26 F N O8 |
|
>98% |
100 MG |
19600 |
chiralix |
CX93797-10G |
Fmoc-D-cyclohexylglycine |
(R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylacetic acid |
198543-96-3 |
379.45 |
C23 H25 N O4 |
Fmoc-D-Chg-OH |
>97% |
10 G |
6000 |
chiralix |
CX93797-25G |
Fmoc-D-cyclohexylglycine |
(R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylacetic acid |
198543-96-3 |
379.45 |
C23 H25 N O4 |
Fmoc-D-Chg-OH |
>97% |
25 G |
13000 |
chiralix |
CX29693-10G |
Fmoc-L-cyclohexylglycine |
(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylacetic acid |
161321-36-4 |
379.45 |
C23 H25 N O4 |
Fmoc-L-Chg-OH |
>97% |
10 G |
6000 |
chiralix |
CX29693-25G |
Fmoc-L-cyclohexylglycine |
(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylacetic acid |
161321-36-4 |
379.45 |
C23 H25 N O4 |
Fmoc-L-Chg-OH |
>97% |
25 G |
13000 |
chiralix |